32 related articles for article (PubMed ID: 15163172)
1. Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
Lee CK; Gurney H; Brown C; Sorio R; Donadello N; Tulunay G; Meier W; Bacon M; Maenpaa J; Petru E; Reed N; Gebski V; Pujade-Lauraine E; Lord S; Simes RJ; Friedlander M
Br J Cancer; 2011 Jul; 105(3):360-5. PubMed ID: 21750553
[TBL] [Abstract][Full Text] [Related]
2. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.
Loprinzi CL; Reeves BN; Dakhil SR; Sloan JA; Wolf SL; Burger KN; Kamal A; Le-Lindqwister NA; Soori GS; Jaslowski AJ; Novotny PJ; Lachance DH
J Clin Oncol; 2011 Apr; 29(11):1472-8. PubMed ID: 21383290
[TBL] [Abstract][Full Text] [Related]
3. Uncomfortably numb: how Nav1.7 mediates paclitaxel-induced peripheral neuropathy.
Silagi ES; Segal RA
Brain; 2021 Jul; 144(6):1621-1623. PubMed ID: 34009327
[TBL] [Abstract][Full Text] [Related]
4. Approach to a patient with chemotherapy-induced peripheral neuropathy: problem-based learning discussion.
Pressler MP; Brenner B; Amgalan A; Mendelson AM
Pain Med; 2024 Apr; 25(4):303-305. PubMed ID: 38128041
[No Abstract] [Full Text] [Related]
5. Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms.
Laforgia M; Laface C; Calabrò C; Ferraiuolo S; Ungaro V; Tricarico D; Gadaleta CD; Nardulli P; Ranieri G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671327
[TBL] [Abstract][Full Text] [Related]
6. [Taxol in the treatment of ovarian neoplasm].
Wang Y; Huang R; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
8. Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery.
Storey DJ; Colvin LA; Mackean MJ; Mitchell R; Fleetwood-Walker SM; Fallon MT
J Pain Symptom Manage; 2010 Jun; 39(6):e2-4. PubMed ID: 20538177
[No Abstract] [Full Text] [Related]
9. Severe neurotoxicity from vinorelbine-paclitaxel combinations.
Parimoo D; Jeffers S; Muggia FM
J Natl Cancer Inst; 1996 Aug; 88(15):1079-80. PubMed ID: 8683640
[No Abstract] [Full Text] [Related]
10. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-26-S15-29. PubMed ID: 9346218
[TBL] [Abstract][Full Text] [Related]
11. Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel.
Fleming GF; Waggoner SE; Rotmensch J; Langhauser C
Am J Clin Oncol; 2001 Feb; 24(1):52-7. PubMed ID: 11232950
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxel.
Scalone S; Sorio R; Bortolussi R; Lombardi D; La Mura N; Veronesi A
Acta Oncol; 2004; 43(2):209-11. PubMed ID: 15163172
[No Abstract] [Full Text] [Related]
13. Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
Aapro MS
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):46-9. PubMed ID: 9364543
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
